Celest Therapeutics (Shanghai) Co., Ltd.
Celest Therapeutics (Shanghai) Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell Injection in Subjects With CLDN18.2-Positive Advanced Malignant Solid Tumors | CLDN18.2 Positive Solid Tumors | Recruiting | Early phase 1 | 2026-07-02 | NCT07680257 | |
| Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Early phase 1 | 2024-11-25 | NCT06652243 |